Who
Michael C. Skaff
10% owner
Company insider
Files Form 4 as: 10% owner, Vivos Therapeutics.
In numbers
- Trades disclosed
- 11
- Buys
- 1
- Sells
- 0
- Bought
- $1.8M
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 31 Mar 2026
- Last trade
- 30 Jun 2026
- Last filed
- 15 Jul 2026
Companies traded
Activity over time
1 Mar – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Jun 2026filed 15 Jul 2026 | VVOS Vivos Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code P | $500K859,166 at $0.582 | filing |
| 30 Jun 2026filed 15 Jul 2026 | VVOS Vivos Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code P | $1.1M1,890,164 at $0.582 | filing |
| 30 Jun 2026filed 15 Jul 2026 | VVOS Vivos Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code P | $1.6M2,749,330 at $0.582 | filing |
| 30 Jun 2026filed 15 Jul 2026 | VVOS Vivos Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code P | $498K859,166 at $0.58 | filing |
| 30 Jun 2026filed 15 Jul 2026 | VVOS Vivos Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code P | $1.1M1,890,164 at $0.58 | filing |
| 30 Jun 2026filed 15 Jul 2026 | VVOS Vivos Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code P | $1.6M2,749,330 at $0.58 | filing |
| 31 Mar 2026filed 2 Apr 2026 | VVOS Vivos TherapeuticsMedical Devices | SEC FORM 4 Bought | $1.4M1,044,777 at $1.34 | filing |
| 31 Mar 2026filed 2 Apr 2026 | VVOS Vivos TherapeuticsMedical Devices | SEC FORM 4 Bought | $414K308,848 at $1.34 | filing |
| 31 Mar 2026filed 2 Apr 2026 | VVOS Vivos Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code P | $576K429,957 at $1.34 | filing |
| 31 Mar 2026filed 2 Apr 2026 | VVOS Vivos Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code P | $2.4M1,783,582 at $1.34 | filing |
| 31 Mar 2026filed 2 Apr 2026 | VVOS Vivos Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code P | $2.4M1,783,582 at $1.34 | filing |
News
Vivos Therapeutics Reports Nasdaq Confirmation of Compliance with Continued Listing Shareholders' Equity StandardVVOS · manilatimes.net · 21 Oct 2026SOD SCIENCES INC.: SOD Sciences Welcomes Vivos Therapeutics as Strategic Investor and Partner in the ReBalU Primed Cell TestVVOS · finanznachrichten.de · 20 Oct 2026Vivos Therapeutics Strikes $12M Stock Deal For SOD Sciences Stake And Test RightsVVOS · rttnews.com · 15 Oct 2026
0 headlines in the last 90 days name Michael C. Skaff; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.